Trademark Search in Canada

IMMUNOONE

View On IC.GC.CA

ADVERTISED

on 12 Feb 2025

Last Applicant/ Owned by

OncoOne Research & Development GmbH

Höhenstraße 19/2A-3400 Klosterneuburg

Serial Number

2237107 filed on 20^th Dec 2022

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

K1P1J9

IMMUNOONE

Trademark usage description

pharmaceutical, and veterinary preparations comprising antibodies, antibody derivatives, and antigen binding fragments for the treatment and preventio Read More

Classification Information

Class [005]
Pharmaceutical, and veterinary preparations comprising antibodies, antibody derivatives, and antigen binding fragments for the treatment and prevention of hyperproliferative and inflammatory diseases; Preparations for medical and veterinary purposes comprising antibodies, antibody derivatives, and antigen binding fragments for the treatment and prevention of hyperproliferative and inflammatory diseases.

Classification kind code

Class [042]
Scientific and technological services for the treatment and prevention of hyperproliferative and inflammatory diseases using antibodies, antibody derivatives, and antigen binding fragments; medical, scientific, and technological research services and analytical laboratory research services for the treatment and prevention of hyperproliferative and inflammatory diseases using antibodies, antibody derivatives, and antigen binding fragments; Pharmaceutical research and development; Research and development in the medical biotechnology field.

Classification kind code

Class [044]
Medical analysis services for the treatment and prevention of hyperproliferative and inflammatory diseases using antibodies, antibody derivatives, and antigen binding fragments; medical testing service for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments; Medical diagnostic services relating to the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments; Medical testing service relating to the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments.

Classification kind code

Mark Details

Serial Number

2237107

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 7^th May 2024	Search Recorded
Submitted for opposition 20 on 7^th May 2024	Examiner's First Report
Submitted for opposition 223 on 7^th May 2024	Total Provisional Refusal
Submitted for opposition 256 on 4^th Dec 2023	Notification of Possible Opposition Sent
Submitted for opposition 48 on 8^th Feb 2023	Agent Changed
Submitted for opposition 257 on 2^th Feb 2023	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 1^st Feb 2023	Formalized
Submitted for opposition 1 on 1^st Feb 2023	Created
Submitted for opposition 228 on 20^th Dec 2022	International Registration
Submitted for opposition 30 on 20^th Dec 2022	Filed